Journal of Clinical Oncology and Cancer Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +447723862070

Editorial - Journal of Clinical Oncology and Cancer Research (2020) Volume 3, Issue 1

Editors prospect for journal of clinical oncology and cancer research.

Giada Bianchi*

Instructor in Medicine, Dana-Farber Cancer Institute, Harvard Medical School, USA

Corresponding Author:
Giada Bianchi
Instructor in Medicine
Dana-Farber Cancer Institute
Harvard Medical School, USA
E-mail: [email protected]

Accepted date: April 25, 2020

Citation: Bianchi G. Editors Prospect for Journal of Clinical oncology and Cancer Research. Allied J Clin Oncol Cancer Res. 2020;3(1):31-32, DOI: 10.35841/cancer-research.3.1.31-32

Visit for more related articles at Journal of Clinical Oncology and Cancer Research


On behalf of the Board of the Journal of Clinical oncology and cancer research and my co-editors I am proud to introduce you to the first fully open access peer-reviewed online journal in cancer. The journal started publishing in 2018 and has since then published several high-quality papers and reviews. Journal of Clinical Oncology and Cancer Research is a peer-reviewed, open access journal that reflects articles on all types of Pathological disorders. Though the journal started recently it has completed 2 volumes successfully and now it is in 3rd volume. This is the result of the work of many people committed to the creation and development of a journal that focuses on standards relevant to the Clinical Oncology and cancer research. Our goal is to provide scholars worldwide with comparative papers on recent developments and research work on Clinical and Experimental Pathological fields on the international level.


Breast cancer, Oncology, Cancer pathobiology


Journal of Clinical Oncology and Cancer Research is a timely resource on cancer pathobiology, which provides a wide range of research arena for every researcher working in cancer biology. The key aspects of journal will cover clinical aspects of cancer, cancer diagnosis in human, cancer diagnostic tools and techniques, Case reports on critical cancer events, Therapeutic paradigm of cancer, of cancer patient’s data, palliatives care for cancer patients, psychological and physical medication for cancer patient, General pathobiology of cancer, recent progresses in cancer treatment etc. The quality of the journal will be maintained higher, practicing original data presentation and ethical clarity. Accuracy and authenticity in the scientific data representation will be given utmost priority for publication.


I am pleased to mention that during the year 2019, all issues of volume 2 were published online well within the time and the print issues were also brought out and dispatched within 30 days of publishing the issue online.

During the calendar year 2019, AACOCR received a total of 530 papers, out of which 477 articles (90%) were rejected in the preliminary screening due to plagiarism or being out of the format. During 2019 around 53 articles were subjected to the peer-review process [1] and 15 of those were accepted and published in our esteemed journal. The primary focus is to publish original research work, Case report, Short Communication, Letter to Editor etc with high standard and novelty along with other types of articles including review articles, short communication, Editorial, case reports, Commentary, Perspectives etc. Authors are being requested to follow individual journal guidelines for further specifications.

In the calendar year 2020, Allied academies are conducting supporting conference to journal. We gladly welcome all the attendees around the world for the hearing of the foremost recent innovations and inventions in the field of cancer [2]. This Conference will provide a place for the exchange of ideas and views by leading scientists, researchers and also from the academicians around the globe. There will be many outstanding keynote speakers and well known leading scientists and experts from various places of the globe to share their ideas and talk about various aspects related to the field of Cancer. Our aim is to gather peer researchers, young scientists, academicians & industrialists to meet, discuss and share the ideas related to it and the knowledge that’s still more to be revealed. We heartily encourage you to attend and contribute to one of the major events of 2020 [3] in the field of Cancer. The conference will reveal the present and future aspects in the field of Cancer which are the need for instant and better treatment.

I would also like to express my gratitude to all the authors, reviewers, the publisher, the advisory and the editorial board of IJPS, the office bearers and staff of IPA secretariat [4] for their support in bringing out yet another volume of AACOCR and look forward to their unrelenting support.

We would like to take this opportunity to thank our reviewers for the effort and expertise that you contribute to reviewing, without which it would be impossible to maintain the high standards of peer-reviewed journals. Who take the time to submit thoughtful contributions to Journal of Clinical Oncology and Cancer Research. We know how much time and effort goes into writing a good peer review, and we deeply value the input of reviewers who volunteer their time [5] and expertise to provide essential feedback that ensures the high quality of research published in each issue of the journal. We appreciate our peer reviewers for taking the time and effort necessary to provide insightful guidance, and we try to show our appreciation to our reviewers. Each year we send letters recognizing the efforts of our best reviewers.


Get the App

Vizag Tech Summit